PROTAC BRD4 Degrader-12 is primarily used in biomedical research to study targeted protein degradation. It is designed to specifically degrade BRD4, a protein involved in regulating gene expression. This application is particularly valuable in cancer research, as BRD4 plays a role in the growth and survival of certain cancer cells. By degrading BRD4, researchers can investigate its role in tumor progression and evaluate potential therapeutic strategies. Additionally, it serves as a tool to explore the PROTAC (Proteolysis Targeting Chimera) technology, which is a promising approach for developing drugs that target previously "undruggable" proteins. Its use aids in understanding cellular mechanisms and advancing drug discovery efforts.